Blood Cancer Discovery

Published by: American Association for Cancer Research  

People

  1. Devlin
    Devlin
  2. Hultcrantz
    Hultcrantz
  3. Lesokhin
    Lesokhin
  4. Levine
    Levine
  5. Maclachlan
    Maclachlan
  6. Maura
    Maura
  7. Shah
    Shah
  8. Shah
    Shah
  9. Usmani
    Usmani
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Center for Hematologic Malignancies (16)
  2. Department of Medicine (16)
  3. Hematologic Malignancies, Division of (16)
  4. GSK Faculty (15)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (11)
  6. Epidemiology and Biostatistics (9)
  7. Executive Committee, Center for Hematologic Malignancies (8)
  8. Hematology-Oncology Fellows (8)
  9. Sloan Kettering Institute Postdocs (8)
  10. Biostatistics Service (7)
Search Within
Formats
  1. Journal Article (18)
  2. Review (4)
  3. Editorial (3)
Groups
  1. Center for Hematologic Malignancies (16)
  2. Department of Medicine (16)
  3. Hematologic Malignancies, Division of (16)
  4. GSK Faculty (15)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (11)
  6. Epidemiology and Biostatistics (9)

More Groups

People
  1. Sean Devlin (4)
  2. Alexander Lesokhin (3)
  3. Elli Papaemmanuil (3)
  4. Francesco Maura (3)
  5. Gunjan Shah (3)
  6. Kylee Maclachlan (3)

More People

Years
  1. 2025 (7)
  2. 2024 (3)
  3. 2023 (3)
  4. 2022 (5)
  5. 2021 (4)
  6. 2020 (3)
Publishers
  1. American Association for Cancer Research (25)

Results (25)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ZBTB33 is mutated in clonal hematopoiesis and myelodysplastic syndromes and impacts RNA splicing
    Journal Article

    Beauchamp, E. M.; Leventhal, M.; Bernard, E.; Hoppe, E. R.; Todisco, G.; Creignou, M.; Galli, A.; Castellano, C. A.; McConkey, M.; Tarun, A.; more...
    Blood Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Toward more complete prognostication for patients with clonal hematopoiesis
    Editorial

    Spitzer, B.; Levine, R. L.
    Blood Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Revealing the impact of structural variants in multiple myeloma
    Journal Article

    Rustad, E. H.; Yellapantula, V. D.; Glodzik, D.; Maclachlan, K. H.; Diamond, B.; Boyle, E. M.; Ashby, C.; Blaney, P.; Gundem, G.; Hultcrantz, M.; more...
    Blood Cancer Discovery (2020)

    Fulltext@MSK | Save
  • Defining an optimal dual-targeted CAR T-cell therapy approach simultaneously targeting BCMA and GPRC5D to prevent BCMA escape– Driven relapse in multiple myeloma
    Journal Article

    de Larrea, C. F.; Staehr, M.; Lopez, A. V.; Ng, K. Y.; Chen, Y.; Godfrey, W. D.; Purdon, T. J.; Ponomarev, V.; Wendel, H. G.; Brentjens, R. J.; more...
    Blood Cancer Discovery (2020)

    Fulltext@MSK | Save
  • COVID-19 infections and clinical outcomes in patients with multiple myeloma in New York City: A cohort study from five academic centers
    Journal Article

    Hultcrantz, M.; Richter, J.; Rosenbaum, C. A.; Patel, D.; Smith, E. L.; Korde, N.; Lu, S. X.; Mailankody, S.; Shah, U. A.; Lesokhin, A. M.; more...
    Blood Cancer Discovery (2020)

    Fulltext@MSK | Save

    • Blood Cancer Discovery – authorized name for:

    Name ISSN / ISBN Publisher
    Blood Cancer Discovery 26433230 The Authors
    Blood cancer discovery 26433249 American Association for Cancer Research
    Blood Cancer Discovery 2643-3230 American Association for Cancer Research
    Blood Cancer Discovery 2643-3230 American Association for Cancer Research
    Blood cancer discovery 26433249 The Authors the American Association for Cancer Research
    Blood Cancer Discovery 26433230 American Association for Cancer Research